Type 1 diabetes trials in Ukraine

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  Where

  Kiev, Kyiv, Uzhhorod, Vinnytsia

  Age

  1 year to 35 years

  People

  300 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07222332 · EU 2025-522170-36-00